Skip to main content

Want a detailed portfolio tracker?

Silence Therapeutics (SLN) P/E (2024 - 2026)

Silence Therapeutics (SLN) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Silence Therapeutics (SLN) P/E is -6.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Silence Therapeutics (SLN)

YearP/EChange
2026-6.83+110.73%
2025-3.24-54.32%
2024-7.09N/A

Comparison Silence Therapeutics (SLN) P/E with competitors

Silence Therapeutics (SLN) P/E is -6.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.10%
FGENFibroGen Inc0.24-103.51%
CHRSCoherus Biosciences Inc0.85-112.42%
FBIOFortress Biotech Inc0.95-113.90%
ORMPOramed Pharmaceuticals Inc1.50-122.01%
AGENAgenus Inc3.01-144.07%
INVAInnoviva Inc3.15-146.18%
VXRTVaxart Inc3.55-151.97%
CRMDCorMedix Inc3.63-153.13%
CVACCureVac N.V.4.45-165.09%
GLPGGalapagos NV4.86-171.14%
SRPTSarepta Therapeutics Inc4.88-171.48%
ABEOAbeona Therapeutics Inc5.39-178.88%
ABUSArbutus Biopharma Corp5.60-181.93%
ZVRAZevra Therapeutics Inc5.89-186.20%
SPROSpero Therapeutics Inc6.23-191.19%
CGENCompugen Ltd6.31-192.45%
RIGLRigel Pharmaceuticals6.87-200.62%
SLXNSilexion Therapeutics Corp7.30-206.83%
OMEROmeros Corporation9.26-235.56%
AUPHAurinia Pharmaceuticals Inc9.58-240.34%
PLXProtalix BioTherapeutics Inc10.89-259.46%
ACADAcadia Pharmaceuticals Inc11.73-271.73%
TBPHTheravance Biopharma Inc12.26-279.54%
ADMAAdma Biologics Inc12.42-281.82%
HRMYHarmony Biosciences Holdings Inc13.82-302.35%
SABSSAB Biotherapeutics Inc14.14-306.98%
NAGENiagen Bioscience Inc14.82-316.96%
INCYIncyte Corp15.82-331.67%
REGNRegeneron Pharmaceuticals Inc15.86-332.17%
PBYIPuma Biotechnology Inc17.32-353.53%
CPRXCatalyst Pharmaceuticals Inc17.44-355.34%
EXELExelixis Inc17.54-356.79%
TGTXTG Therapeutics Inc18.97-377.69%
MDXGMimedx Group Inc20.55-400.92%
XOMAXOMA Royalty Corp22.87-434.93%
ARGXArgen X SE24.30-455.77%
CTMXCytomX Therapeutics Inc24.82-463.43%
XOMAOXOMA Royalty Corp25.34-471.10%
HALOHalozyme Therapeutics Inc25.62-475.18%
XOMAPXOMA Royalty Corp25.67-475.86%
VRTXVertex Pharmaceuticals Inc27.99-509.90%
RPRXRoyalty Pharma plc - Class A28.69-520.04%
SLNOSoleno Therapeutics Inc29.02-524.84%
ASNDAscendis Pharma A/S30.09-540.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91-655.11%
APLSApellis Pharmaceuticals Inc39.02-671.35%
BMRNBiomarin Pharmaceutical Inc42.21-718.07%
KRYSKrystal Biotech Inc45.34-763.92%
ONCBeiGene Ltd69.54-1118.22%
PHARPharming Group N.V.75.03-1198.53%
TECHBio-Techne Corp101.96-1592.88%
VCELVericel Corp109.92-1709.48%
ALNYAlnylam Pharmaceuticals Inc117.96-1827.25%
GMABGenmab140.29-2154.15%
TLXTelix Pharmaceuticals Ltd162.15-2474.25%
CORTCorcept Therapeutics Inc212.86-3216.68%